In experimental renovascular hypertension with preserved kidney mass (2K1C), the renin-angiotensin-aldosterone system (RAAS) is found to be activated [12], and central nervous system effects of angiotensin II probably are the driving force of sympathoactivation [13]. This evidence concerns the gene REN and renovascular hypertension.